The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Our portfolio contains sedatives, muscle relaxants, analgesics, antibiotics, antidotes, antiemetics and many more products for a wide variety of therapeutic and effective areas.
Doctors, pharmacists and nursing staff in more than 55 countries appreciate our experience and know-how in the field of injectable dosage forms.
Our labelling is constantly evolving using intelligent packaging design to help reduce the risk of medication errors. We have also developed standardised drug infusion concentrations (Ready-to-Use solutions).
Working for people’s wellbeing – this approach is ingrained in our company’s DNA. As a fourth-generation owner-managed company, we have been established since 1890 and have contributed to the supply of vital medicines in a variety of ways.
Our driving force is the understanding that we can all be patients. That’s why we utilize all of our knowledge and skills every day in order to make the supply of medicines to patients around the world as safely and reliably as possible.
Find out more about hameln pharma and our products on our website www.hameln-pharma.com.